MIT Sloan School of Management

HawkEye 360 Announces Patrick Zeitouni as Chief Strategy Officer

Retrieved on: 
Wednesday, January 18, 2023
Georgia Tech, Blue Origin, Navigation, Partner, Electrical engineering, McKinsey & Company, HawkEye 360, University, Communication, RF, Defense, Northrop Grumman, Government, Massachusetts Institute of Technology, Northrop, Knowledge, U.S. Department of Defense Strategy for Operating in Cyberspace, NASA, Unitary state, Grumman, Moon, Intelligence, Spacecraft, MIT Sloan School of Management, Ministry of Education (Malaysia), Hawk-Eye, MBA, Management, Communications satellite, Electricity, Ofer Zeitouni

HERNDON, Va., Jan. 18, 2023 /PRNewswire/ -- HawkEye 360 Inc., the world's leading commercial provider of space-based radio frequency (RF) data and analytics, announced today the addition of Patrick Zeitouni, former head of space mobility at Blue Origin, to its leadership team.

Key Points: 
  • As Chief Strategy Officer, Mr. Zeitouni will guide the company through an evolving space and national security landscape, driving company growth and product strategy in a rapidly expanding RF data and analytics market.
  • "I have known and respected the HawkEye 360 leadership team for several years, and it is an absolute honor to have the opportunity to join the company," said Mr. Zeitouni.
  • Mr. Zeitouni comes to HawkEye 360 with a breadth of experience gained over a long and successful career.
  • "Patrick Zeitouni will be a tremendous addition to the HawkEye 360 team.

ASRC Federal Taps Sanjay Sardar as Civilian & Health Operating Group President

Retrieved on: 
Tuesday, January 17, 2023
ACT, General Dynamics, Business administration, Master of Business Administration, University, Leukemia, AFCEA, FERC, MIT Sloan School of Management, Aviation, Federal Energy Regulatory Commission, University of Virginia, Public health, Digital transformation, Food, SAIC, ASRC, Growth, Multifunction Advanced Data Link, American Heart Association, George Washington University School of Business, MBA, Business, Arctic Slope Regional Corporation, Management, Oracle

RESTON, Va., Jan. 17, 2023 /PRNewswire/ -- ASRC Federal has named Sanjay Sardar president of the company's Civilian & Health operating group. Sardar brings decades of experience in the federal civilian and health markets and will provide strategic leadership and programmatic and technical oversight for the operating group, which focuses on delivering mission-enabling information technology, data analytics and business solutions to federal government customers.

Key Points: 
  • RESTON, Va., Jan. 17, 2023 /PRNewswire/ -- ASRC Federal has named Sanjay Sardar president of the company's Civilian & Health operating group.
  • Sardar brings decades of experience in the federal civilian and health markets and will provide strategic leadership and programmatic and technical oversight for the operating group, which focuses on delivering mission-enabling information technology, data analytics and business solutions to federal government customers.
  • "Sanjay understands how delivering smart, technology-based solutions can benefit our federal customers' missions, from safe aviation and food supply to public health," said ASRC Federal President and CEO Jennifer Felix.
  • "I am inspired by the immensely talented team at ASRC Federal, whose level of expertise, capabilities and passion for supporting our customers will be key to our continued growth and success," said ASRC Federal Civilian & Health operating group president Sanjay Sardar.

MIT Sloan book says we need to do a lot more to prevent and prepare for climate catastrophes

Retrieved on: 
Tuesday, January 17, 2023
Climate change, Bank, Erosion, Temperature, MIT Sloan School of Management, COVID-19, Uncertainty, Public sector banks in India, Welfare, CO2, Policy, History, Growth, Coral Reefs, Pacific typhoon season, GHG, Management, Public policy, GDP, Renewable energy, Aquaculture, Agriculture, Economics, Climate, Robert Pindyck

CAMBRIDGE, Mass., Jan. 17, 2023 /PRNewswire/ -- A new book by an economist at MIT Sloan School of Management argues that despite efforts to reduce emissions worldwide, severe climate change is likely inevitable in the not-too-distant future and we must invest now in strategies and technologies to help us adapt to rising temperatures and sea levels.

Key Points: 
  • Climate Future: Averting and Adapting to Climate Change, by MIT Sloan economist Robert S. Pindyck explains what we know and don't know about climate change, and what we can do to prepare for a possible climate catastrophe.
  • He says federal, state, and local governments need to invest in adaptations to counter current and future fallout from climate change.
  • Exactly how much will temperatures and sea levels rise, and how will this impact our economic and social welfare?
  • Because today's climate policy decisions have both short-term costs and long-term economic implications, it would be wrong to take a "wait-and-see" approach.

Myron Scholes Named S. Donald Sussman Award Recipient by MIT Sloan School of Management

Retrieved on: 
Thursday, January 12, 2023
Janus, Nobel Prize, Platinum, Financial engineering, Janus Henderson, Empirical research, University, Scholes, Stanford Graduate School of Business, Accenture, Doctor of Philosophy, Long-Term Capital Management, Uncertainty, Partnership, MIT Sloan School of Management, Risk, Faculty, Carbon, MIT, Economics, Policy, McMaster University, Prentice Hall, Laboratory, Fischer Black, Research, Risk management, Science, University of Chicago Booth School of Business, Salomon Brothers, Tax, MBA, International business strategy, Education, Chicago (franchise), Paganini Competition, Management, Business, Stanford University

CAMBRIDGE, Mass., Jan. 12, 2023 /PRNewswire/ -- The MIT Sloan School of Management recently announced that Myron Scholes, Frank E. Buck Professor of Finance, Emeritus, at the Stanford Graduate School of Business, Nobel Laureate in Economic Sciences, and co-originator of the Black-Scholes/Merton option pricing model, was named the recipient of the S. Donald Sussman Award for the 2023–2024 academic year.The honor is awarded to individuals or groups who best exemplify S. Donald Sussman's career as a successful investor in quantitative investment strategies and models. Scholes was selected for his path breaking contributions to this field, as well as his research focused on understanding uncertainty and its effect on asset prices and the value of options.

Key Points: 
  • CAMBRIDGE, Mass., Jan. 12, 2023 /PRNewswire/ -- The MIT Sloan School of Management recently announced that Myron Scholes , Frank E. Buck Professor of Finance, Emeritus, at the Stanford Graduate School of Business , Nobel Laureate in Economic Sciences, and co-originator of the Black-Scholes/Merton option pricing model, was named the recipient of the S. Donald Sussman Award for the 2023–2024 academic year.
  • "Myron Scholes captures the essence of the Sussman Award as a finance scholar of the highest caliber who has also taken theory into investment practice successfully on multiple occasions," said MIT Sloan professor Andrew Lo , director of MIT Sloan's Laboratory for Financial Engineering, and a member of the award committee.
  • "I am excited to return to MIT Sloan to receive the Sussman Award.
  • Scholes continued his academic career with faculty positions at the University of Chicago Booth School of Business and Stanford University.

Organizations must step up manager support in 2023, according to RedThread Research

Retrieved on: 
Wednesday, January 11, 2023
HR, Communication, NPS, MIT Sloan School of Management, Organization, Environment, Mehrotra, Growth, Research, Map, Redthread, READ, GPS, Management, Risk management, Tutoring

WOODSIDE, Calif., Jan. 11, 2023 /PRNewswire-PRWeb/ -- Manager engagement and effectiveness dipped significantly in 2022, according to a new report from RedThread research, "Managing Better in 2023: It Starts with You," by Stacia Garr and Priyanka Mehrotra. Based on a survey of more than 700 employees, together with interviews and other research, it captures a moment when managers across industries have begun to backslide.

Key Points: 
  • Manager engagement and effectiveness declined last year, according to new RedThread Research.
  • To get back on track, organizations must provide managers and employees with the support they need to excel.
  • Now organizations are trying to pull back to pre-pandemic levels, but employees like and need the support they got in 2020."
  • For complete access to the latest research in performance management, human resources, and workforce learning and development strategies, become a RedThread Research member.

XtalPi Names New COO for U.S. Operations, Bringing Its Autonomous Labs to Boston in Continued Global Expansion

Retrieved on: 
Wednesday, January 11, 2023
Mentorship, MIT, Greater Boston, Drug discovery, Automation, Merck & Co., Artificial intelligence, Merck, Female, Laboratory, MIT Sloan School of Management, MBA, Inc., Growth, Patient, AI, University, Chemistry, Robotics, Medical device, Management

Dr. Trice will report directly to XtalPi CEO Dr. Jian Ma, leading the company's growth strategy and corporate operations in the U.S. and European markets.

Key Points: 
  • Dr. Trice will report directly to XtalPi CEO Dr. Jian Ma, leading the company's growth strategy and corporate operations in the U.S. and European markets.
  • Dr. Trice has spent over 17 years building a celebrated career across the life science and pharmaceutical sectors.
  • Prior to joining XtalPi, Dr. Trice co-founded Entos, Inc., an AI-driven biotechnology company, where she oversaw all day-to-day operations and directed external business activities as the COO.
  • At XtalPi, Dr. Trice will be responsible for driving XtalPi's business expansion in the U.S. and European markets, including spearheading the establishment of a next-generation autonomous lab in the Greater Boston Area.

AMS Announces Principal Patricia Yanes as Testifying Survey Expert, Authority in Applying Conjoint Analysis as a Basis for Damages Models in Class Actions

Retrieved on: 
Tuesday, January 10, 2023
MaxDiff, Society for Women's Health Research, INFORMS, AMS, TURF, Advertising, Insights Association, Economics, AAPOR, MIT Sloan School of Management, Boston College, Woman, Science, Behavior, American Association for Public Opinion Research, Yanes, Management science, Operations research, Public opinion, Bentley University, Consumer, Wire, Marketing, 3D printing, Business, Research

WALTHAM, Mass., Jan. 10, 2023 /PRNewswire-PRWeb/ -- Applied Marketing Science, Inc. (AMS), a leading-edge market research and consulting firm, is pleased to announce that Principal and Discrete-Choice Methodology Lead Patricia (Patty) Yanes joins the firm's expanding network of testifying survey experts. AMS will support Yanes in complex litigation involving survey evidence and expert witness testimony, with a focus on applying conjoint analysis and other methodologies as a basis for determining damages in class actions and other civil litigation.

Key Points: 
  • AMS will support Yanes in complex litigation involving survey evidence and expert witness testimony, with a focus on applying conjoint analysis and other methodologies as a basis for determining damages in class actions and other civil litigation.
  • For more than a decade Yanes has led both domestic and international research engagements in business-to-business and consumer markets at AMS.
  • She has successfully managed projects with testifying experts working on cases related to deceptive advertising, class actions, patent infringement and more.
  • For additional information on AMS Litigation Support services, please send inquiries to [email protected] or contact Jason Och at (781) 250-6317.

Ncardia and Cellistic recruit Gustavo Mahler to lead the businesses through their next phase of growth

Retrieved on: 
Thursday, January 5, 2023
Science, Stem Cells, Biotechnology, Research, Pharmaceutical, General Health, Health, Genetics, Management, IPSC, GMP, Doctor of Philosophy, Drug development, Multimedia, Norwest Venture Partners, MBA, AGC, Jethro Leadership Management Institute, Jian Wang (cellist), Growth, Investment, University, University of Buenos Aires, Charles III University of Madrid, MIT Sloan School of Management, Bayer, Sale, Biochemistry

Ncardia and Cellistic continue to build their leadership teams by recruiting Gustavo Mahler as Chief Executive Officer.

Key Points: 
  • Ncardia and Cellistic continue to build their leadership teams by recruiting Gustavo Mahler as Chief Executive Officer.
  • Gustavo was most recently a Venture Partner with DYNAMK Capital where he invested in leading life sciences tools, technologies, and services.
  • Prior to this role Gustavo spent ten years leading and growing CMC Biologics (now AGC Biologics) resulting in CMC’s sale to Asahi Glass Corporation for €520 million which created AGC Biologics.
  • “We are thrilled with the continued growth and expansion of Ncardia and Cellistic,” said Geoff Glass, Chairman of Ncardia and Cellistic.

Poets&Quants Names Most Disruptive MBA Startups Of 2022

Retrieved on: 
Tuesday, December 20, 2022
London Business School, Harvard Business School, Wharton School of the University of Pennsylvania, Kellogg School, Education, University of Chicago Booth School of Business, The Garage at Northwestern University, Undergrads, University, Growth, Medicine, MIT Sloan School of Management, Gas flare, Agriculture, News, Food, Therapy, MBA, INSEAD, Wendell Pritchett, MIT, Management, Gander

CARY, N.C., Dec. 20, 2022 /PRNewswire/ -- Poets&Quants, the leading news source for graduate business education, has released its 4th annual "Most Disruptive MBA Startups" feature, which honors 43 MBA startups that are boosting capabilities and empowering customers in their industries.

Key Points: 
  • CARY, N.C., Dec. 20, 2022 /PRNewswire/ -- Poets&Quants, the leading news source for graduate business education, has released its 4th annual "Most Disruptive MBA Startups" feature, which honors 43 MBA startups that are boosting capabilities and empowering customers in their industries.
  • This year, the "Most Disruptive MBA Startups" covered most of the top industries: finance, energy, food, aerospace, medicine, agriculture, and education.
  • To qualify, a school nomination must feature at least one founding MBA from the Class of 2022.
  • The "Most Disruptive MBA Startups" is another Poets&Quants feature designed to recognize the world's top business students.

Verastem Oncology Appoints Rob Gagnon to Board of Directors

Retrieved on: 
Thursday, December 15, 2022
Oncology, Health, Other Health, General Health, Pharmaceutical, Biotechnology, MIT Sloan School of Management, Mirati, RAF, RAMP, Management, FAK, Oncology, Amgen, Harvard Bioscience, NSCLC, Security (finance), Controller, Food, Regenerative medicine, RAS, LLP, Regulation of tobacco by the U.S. Food and Drug Administration, Bentley University, ARAF, Cancer, BRAF, Government, Biogen, Clean Harbors, MEK, MBA, Research, Breakthrough therapy, Patent, CRAF, PricewaterhouseCoopers, Patient, KRAS, Hospital, Pharmaceutical industry, Medical imaging, Verastem Oncology

Verastem Oncology (Nasdaq:VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the appointment of Robert Gagnon to its Board of Directors, effective December 13, 2022.

Key Points: 
  • Verastem Oncology (Nasdaq:VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the appointment of Robert Gagnon to its Board of Directors, effective December 13, 2022.
  • I am excited to contribute to Verastem in this new capacity by joining the distinguished and dedicated Board of Directors and contribute to Verastems continued progress.
  • Mr. Gagnon has more than 20 years of financial and commercial experience in heading global finance operations.
  • Verastem Oncology (Nasdaq: VSTM) (Verastem, Inc.) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer.